Navigation Links
DICOM Grid Selected as a Finalist for the 2012 Red Herring Top 100 Americas Award
Date:5/14/2012

PHOENIX, May 14, 2012 /PRNewswire/ -- DICOM Grid announced today it has been selected as a Finalist for Red Herring's Top 100 Americas award, a prestigious list honoring the year's most promising private technology ventures from the North American business region.

The Red Herring editorial team selected the most innovative companies from a pool of hundreds from across North America. The nominees are evaluated on both quantitative and qualitative criteria, such as financial performance, technology innovation, quality of management, execution of strategy, and integration into their respective industries.

This unique assessment of potential is complemented by a review of the actual track record and standing of a company, which allows Red Herring to see past the "buzz" and make the list a valuable instrument for discovering and advocating the greatest business opportunities in the industry.

"This year was very rewarding," said Alex Vieux, publisher and Chairman of Red Herring. "There are so many great companies producing truly innovative and amazing products and technologies. We had a very difficult time narrowing the field and selecting the Finalists from such a group of future stars. DICOM Grid shows great promise therefore deserves to be on the short list. Now we are faced with the difficult task of selecting the Top 100 winners."

"Healthcare IT is a critical component in fixing what ails our nation's healthcare system," Morris Panner, CEO of DICOM Grid said.  "We are honored to be included in this prestigious group and are grateful for the support it represents as we take our message of innovation to the medical and hospital community."

DICOM Grid provides a software-platform for managing and storing diagnostic imaging.  DG Suite, its flagship product, enables hospitals and healthca
'/>"/>

SOURCE DICOM Grid
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Syndicom SpineConnect Web Platform Chosen for Applied Spines Leg and Back Pain Clinical Trial of Its Stabilimax NZ(R) Dynamic Spine Stabilization System
2. Medical Imaging Solutions Firm Dicom Solutions Ranks No. 109 on the Inc. 500
3. Medicomps Decipher Holter Monitor Provides Cardiac Reporting on the International Space Station
4. Acuo Technologies Announces Implementation and Acceptance of Acuos DICOM Services Grid(TM) With Lancaster General Hospital
5. Wolters Kluwer Health Enters Joint Venture with China Drug Information Provider Medicom
6. Medicomp, Inc. Announces Company Purchase From United Therapeutics
7. Medicomp Releases ICD-10-CM with New Version of the Powerful MEDCIN Engine®
8. Medicomp Systems Announces Partnership to Integrate Quippe® into MED3OOO Product
9. ONRAD, Inc. Chooses Dicom Systems Vendor Neutral Archive
10. Medicomp Systems Hosts Quipstar, Worlds Favorite HIT Quiz Show, at HIMSS12
11. Zila Inc. Product Selected to Identify Pre-Cancer in Study of Leading Cancer Treatment Chemotherapeutic - ERBITUX
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... and LYON, France , Dec. ... LLY ) and Adocia (Euronext Paris: FR0011184241 – ... developing an ultra-rapid insulin, known as BioChaperone Lispro, for ... diabetes. BioChaperone Lispro relies on Adocia,s proprietary BioChaperone® technology ... Lilly and Adocia will develop BioChaperone Lispro with the ...
(Date:12/17/2014)... , December 17, 2014 Revenue and ... expenditure on research and development In the past ... revenue by two percent to EUR 4.287 billion (last year: ... by 14 percent to EUR 360 million. "Overall, 2013/14 was ... Michael Kaschke , President and CEO of Carl Zeiss ...
(Date:12/17/2014)... Ariz. , Dec. 17, 2014  Beamz ... state-of-the-art interactive music products, today announced that it ... a leading manufacturer and supplier of innovative prosthetic, ... As part of the agreement, RSL Steeper ... bundled solution specifically configured for use within UK ...
Breaking Medicine Technology:Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 2Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 3ZEISS Asserts its Position in Difficult Environment 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 3
... NEWTOWN, Pa., Dec. 1, 2011 HeartSine ® Technologies, ... announced today that it is the exclusive provider of ... nation,s second largest nursing facility company. As part ... Access Defibrillator , HeartSine,s lifesaving product for the treatment ...
... (Nasdaq: MYL ) today announced that its ... received tentative approval from the U.S. Food and Drug ... Relief (PEPFAR) for its New Drug Application (NDA) for ... This product is the first heat-stable, fixed-dose ...
Cached Medicine Technology:HeartSine® Technologies Now Exclusive Provider of Lifesaving AEDs to Golden LivingCenters 2HeartSine® Technologies Now Exclusive Provider of Lifesaving AEDs to Golden LivingCenters 3Mylan Receives Tentative FDA Approval Through PEPFAR for First Heat-Stable, Fixed-Dose Combination of Atazanavir Sulfate and Ritonavir Tablets for HIV/AIDS 2
(Date:12/20/2014)... Xarelto bleeding lawsuits filed by men and ... other serious side effects will be consolidated in the ... pretrial proceedings, Wright & Schulte LLC reports. The U.S. ... Friday to transfer 21 Xarelto lawsuits and over 30 ... the Louisiana district court for coordination by Judge Eldon ...
(Date:12/19/2014)... 20, 2014 Today, Balfleet.com , ... outfits, announces its formal dress promotion. All the old ... to 60% off. , Balfleet.com is well-known for its ... dresses, prom dresses, cocktail dresses and more. Its formal ... money-back guarantee, and they can create an elegant look ...
(Date:12/19/2014)... 19, 2014 Energy Textiles is ... now available. Celliant, the world’s leading responsive textile, ... pillowcases. , There are a number of benefits ... increased oxygenation and balanced body temperature; which can ... pain relief; enhanced athletic performance; and overall wellness. ...
(Date:12/19/2014)... 19, 2014 Eufaula, Oklahoma, located just ... Eufaula, the state’s largest lake with more than 600 ... home to a little more than 3,000 residents, hosted ... Saturday, the 6th of December. , Featuring Santa, Christmas ... downtown Eufaula on Main Street. Narconon Arrowhead’s parade ...
(Date:12/19/2014)... December 20, 2014 The print component ... and Business subscription of the Toronto Star, with a ... of 622,169. The digital component is distributed nationally through ... of top news sites and partner outlets. To explore ... . , The publication features an exclusive interview ...
Breaking Medicine News(10 mins):Health News:Xarelto Bleeding Lawsuits Consolidated To Louisiana Federal Court For Multi-District Litigation Reports Wright & Schulte LLC 2Health News:Xarelto Bleeding Lawsuits Consolidated To Louisiana Federal Court For Multi-District Litigation Reports Wright & Schulte LLC 3Health News:Xarelto Bleeding Lawsuits Consolidated To Louisiana Federal Court For Multi-District Litigation Reports Wright & Schulte LLC 4Health News:Balfleet.com Announces Its Formal Dress Promotion For 2015 2Health News:Energy Textiles Launches Celliant Revitalizing Bedsheets 2Health News:Narconon Arrowhead Debuts Float at Checotah and Eufaula Christmas Parades 2Health News:Narconon Arrowhead Debuts Float at Checotah and Eufaula Christmas Parades 3Health News:Mark DeMontis, Founder of Courage Canada, shares his passion for bringing hockey to those affected by blindness in Mediaplanet’s “Vision and Hearing” campaign 2
... Service Corporation,s Technology Investments Streamline ... HealthLeaders-InterStudy, NASHVILLE, Tenn., Aug. 5 ... intelligence, reports that Health,Care Service Corporation is ... serve its members. According to the,new report ...
... (Nasdaq: NKTR ) today announced the company,s financial ... 2008., Cash, cash equivalents, and short-term investments were ... at March 31, 2008., Revenue for the three ... to revenue of $65.9 million in the second quarter ...
... 6 Nektar,Therapeutics (Nasdaq: NKTR ) today ... the position of Senior Vice President of Drug,Development ... Dr.,Moreadith will report to Nektar,s President and Chief ... lead Clinical Drug Development, Clinical,Pharmacology and Toxicology, and ...
... 9.3 percent (constant currency) - Execution of strategic ... guidance based on year-to-date ... performance and operational momentum, BATESVILLE, Ind., Aug. 6 ... results for its fiscal,third quarter ended June 30, 2008 -- ...
... Pa., Aug. 6 West Pharmaceutical,Services, Inc. (NYSE: ... Vice,President and Chief Financial Officer, and Michael Anderson, ... will be presenting at,the CJS Securities 8th Annual ... NY, on August 12, 2008. A copy of ...
... A drug-like molecule called Wnt can be substituted for ... to adult cells to reprogram them to an embryonic-stem-cell-like ... embryonic stem-cell-like cells, known as induced pluripotent (IPS) cells, ... diabetes. , Demonstrated in mice, the elimination of ...
Cached Medicine News:Health News:Insurance Giant Leverages Technology to Enhance Offerings 2Health News:Nektar Therapeutics Announces Second Quarter 2008 Results 2Health News:Nektar Therapeutics Announces Second Quarter 2008 Results 3Health News:Nektar Therapeutics Announces Second Quarter 2008 Results 4Health News:Nektar Therapeutics Announces Second Quarter 2008 Results 5Health News:Nektar Therapeutics Announces Second Quarter 2008 Results 6Health News:Nektar Therapeutics Announces Second Quarter 2008 Results 7Health News:Nektar Therapeutics Announces Second Quarter 2008 Results 8Health News:Nektar Therapeutics Names Randall Moreadith, M.D., Ph.D. Senior Vice President, Drug Development and Chief Development Officer 2Health News:Nektar Therapeutics Names Randall Moreadith, M.D., Ph.D. Senior Vice President, Drug Development and Chief Development Officer 3Health News:Hill-Rom Reports Third Quarter Revenue Growth of 11.7 Percent to $366.8 Million and Earnings Per Fully Diluted Share From Continuing Operations of $0.34, an Increase of 89 Percent From the Prior Year 2Health News:Hill-Rom Reports Third Quarter Revenue Growth of 11.7 Percent to $366.8 Million and Earnings Per Fully Diluted Share From Continuing Operations of $0.34, an Increase of 89 Percent From the Prior Year 3Health News:Hill-Rom Reports Third Quarter Revenue Growth of 11.7 Percent to $366.8 Million and Earnings Per Fully Diluted Share From Continuing Operations of $0.34, an Increase of 89 Percent From the Prior Year 4Health News:Hill-Rom Reports Third Quarter Revenue Growth of 11.7 Percent to $366.8 Million and Earnings Per Fully Diluted Share From Continuing Operations of $0.34, an Increase of 89 Percent From the Prior Year 5Health News:Hill-Rom Reports Third Quarter Revenue Growth of 11.7 Percent to $366.8 Million and Earnings Per Fully Diluted Share From Continuing Operations of $0.34, an Increase of 89 Percent From the Prior Year 6Health News:Hill-Rom Reports Third Quarter Revenue Growth of 11.7 Percent to $366.8 Million and Earnings Per Fully Diluted Share From Continuing Operations of $0.34, an Increase of 89 Percent From the Prior Year 7Health News:Hill-Rom Reports Third Quarter Revenue Growth of 11.7 Percent to $366.8 Million and Earnings Per Fully Diluted Share From Continuing Operations of $0.34, an Increase of 89 Percent From the Prior Year 8Health News:Hill-Rom Reports Third Quarter Revenue Growth of 11.7 Percent to $366.8 Million and Earnings Per Fully Diluted Share From Continuing Operations of $0.34, an Increase of 89 Percent From the Prior Year 9Health News:Hill-Rom Reports Third Quarter Revenue Growth of 11.7 Percent to $366.8 Million and Earnings Per Fully Diluted Share From Continuing Operations of $0.34, an Increase of 89 Percent From the Prior Year 10Health News:Hill-Rom Reports Third Quarter Revenue Growth of 11.7 Percent to $366.8 Million and Earnings Per Fully Diluted Share From Continuing Operations of $0.34, an Increase of 89 Percent From the Prior Year 11Health News:Hill-Rom Reports Third Quarter Revenue Growth of 11.7 Percent to $366.8 Million and Earnings Per Fully Diluted Share From Continuing Operations of $0.34, an Increase of 89 Percent From the Prior Year 12Health News:Hill-Rom Reports Third Quarter Revenue Growth of 11.7 Percent to $366.8 Million and Earnings Per Fully Diluted Share From Continuing Operations of $0.34, an Increase of 89 Percent From the Prior Year 13Health News:Hill-Rom Reports Third Quarter Revenue Growth of 11.7 Percent to $366.8 Million and Earnings Per Fully Diluted Share From Continuing Operations of $0.34, an Increase of 89 Percent From the Prior Year 14Health News:Recipe for cell reprogramming adds protein 2
The Clearview hCG Test is for the rapid detection of human chorionic gonadotropin (hCG) in urine specimens. This test kit is used to obtain a visual, qualitative result and is intended for professio...
... the finest surgical-quality loupes available ... standard for innovative optical design, combining ... Delivering optimum performance with maximum comfort, ... for medical professionals worldwide. All SheerVision ...
... Experience the finest surgical-quality loupes available ... the standard for innovative optical design, ... Delivering optimum performance with maximum comfort, ... for medical professionals worldwide. Make both ...
... SheerVision have addressed a key need of ... with light-weight comfort for everyday use. ... as 1.5 ounces when included with a ... either a flip-up or through-the-lens (TTL) design. ...
Medicine Products: